Chitin, Chitosan, and Derivatives Industry to Witness Rapid Development during the Period 2020– 2027
Market Highlights
Chitin, Chitosan and Derivatives
Market has witnessed significant growth over
the last few years and is projected to reach by USD 8,531.7 Million by
2025 at a CAGR of 8.7% from 2019 to 2025. Chitin
is a natural polysaccharide found in crustacean shells, insect skin, and the
cell walls of fungal species. Chitin and its derivatives such as chitosan and
glucosamine find application in various industries. The major raw materials
used to produce chitin and its derivatives are shrimp, crab, squid, lobster,
insects, fungi, and yeasts. Chitin is a natural and main structural component
of the exoskeleton of crustaceans. In insects, chitin is found in the cuticle,
whereas, in fungi and yeast it is found in the cell walls. Crustacean shells
are the largest source for the industrial production of chitin as it is
inexpensive, rich in chitin, and available in abundance as a waste or
by-product. Manufacturers of chitin and its derivatives are opting for
sustainability and economic efficiency by utilizing crustacean waste, i.e.,
shells and skins, to produce chitin and its derivatives. The market is expected
to be lucrative for the players during the forecast period due to the rising
demand for natural ingredients in various application industries. However, the
unsustainable and inconsistent production of chitin is restricting the growth
of the market.
Segmental Analysis
The global chitin,
chitosan, and derivatives industry has been segmented on the basis of type,
application, and region.
Based on type, the global market has
been divided into chitin, chitosan, glucosamine, and others. In terms of
revenue, the chitosan segment dominated the global chitin, chitosan, and
derivatives market in 2018. However, the glucosamine segment is projected
to register the highest CAGR of 9.1% during the forecast period. The surging
demand for glucosamine as a dietary supplement in the nutraceutical industry is
the major factor contributing to the growth of the segment.
By application, the market has been
categorized as food & beverages, pharmaceuticals & nutraceuticals,
animal feed, agriculture, and others. The pharmaceuticals & nutraceuticals
segment garnered the largest share of the global chitin, chitosan, and
derivatives market in 2018. In the nutraceuticals industry, chitin and its
derivatives, such as glucosamine, are used in dietary supplements to aid the
treatment of kidney disorders, arthritis, and heart diseases. However, the food
& beverage segment is expected to register the highest CAGR during the
forecast period.
Regional Analysis
Geographically, the global
chitin, chitosan, and derivatives market
has been segmented into North America, Europe, Asia-Pacific, South America, and
the Middle East & Africa. As per MRFR analysis, North America dominated the
market, accounting for the largest market share of nearly 32%, in 2018.
However, the Asia-Pacific chitin, chitosan, and derivatives market is expected
to register the highest CAGR of 9.3% during the forecast
period of 2019 to 2025.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/chitin-chitosan-derivatives-market-8589
Key Players
Market Research Future recognizes Advanced Biopolymers AS (Norway), G.T.C. Bio Corporation (China),
Golden-Shell Pharmaceutical Co. Ltd. (China), Heppe Medical Chitosan GmbH
(Germany), Kitozyme, LLC (Belgium), Zhejiang Shinfuda Marine Biotechnology
Corp. (China), Meron Group (India), Primex EHF (Iceland), Zhejiang Candorly
Pharmaceutical Co. (China), and Panvo Organics Pvt Ltd (India) as
the Key Players active in the Global Chitin, Chitosan
and Derivatives Market.
Key Findings of the Study
- The Global Chitin, Chitosan and Derivatives Market is
expected to register a growth rate of 7% between 2019 and 2025.
Increasing demand for natural food ingredients is anticipated to propel
the growth of the global chitin, chitosan, and derivatives market.
- By type, the chitosan segment is estimated to hold the largest
market share during the forecast period and is projected to register a
growth rate of 7%.
- On the basis of application, the pharmaceuticals &
nutraceuticals segment is projected to maintain its dominance from 2019
to 2025. The segment is expected to register a substantial growth rate
of 5% during the forecast period.
NOTE: Our Team of Researchers are
Studying Covid19 and its Impact on Various Industry Verticals and wherever
required we will be considering Covid19 Footprints for Better Analysis of
Market and Industries. Cordially get in Touch for More Details.
Comments
Post a Comment